Zuranolone, a GABAA receptor positive allosteric modulator: safety from SKYLARK, a phase 3 placebo-controlled study in adults with postpartum depression
Fields of Study & Subjects
Tryptophan and brain disorders
Neuroscience and Neuropharmacology Research
Neuroendocrine regulation and behavior
Publication details
- Journal / source
- Neuroscience Applied
- Volume
- 5
- Pages
- 106039–106039
- Publication date
- 1 January 2026
- Language
- EN